Schizophrenia Research
Volume 63, Issue 3 , Pages 219-227 , 1 October 2003

Cognitive mechanisms, psychosocial functioning, and neurocognitive rehabilitation in schizophrenia

  • Rafael Penadés

      Affiliations

    • Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain
    • ,
  • Teresa Boget

      Affiliations

    • Corresponding Author InformationCorresponding author. Servei de Psicologia Clı́nica, Hospital Clı́nic i Provincial, Villarroel 170, 08036 Barcelona, Spain. Tel.: +34-93-227-5477; fax: +34-93-227-5477
    • Clinical Institute of Psychiatry and Psychology, Hospital Clı́nic, Barcelona, Spain
    • ,
  • Rosa Catalán

      Affiliations

    • Clinical Institute of Psychiatry and Psychology, Hospital Clı́nic, Barcelona, Spain
    • ,
  • Miquel Bernardo

      Affiliations

    • Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain
    • Clinical Institute of Psychiatry and Psychology, Hospital Clı́nic, Barcelona, Spain
    • ,
  • Cristobal Gastó

      Affiliations

    • Clinical Institute of Psychiatry and Psychology, Hospital Clı́nic, Barcelona, Spain
    • ,
  • Manel Salamero

      Affiliations

    • Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain
    • Clinical Institute of Psychiatry and Psychology, Hospital Clı́nic, Barcelona, Spain

Received 17 August 2001 ,Accepted 14 July 2002.

References 

  1. Bellack AS, Gold JM, Buchanan RW. Cognitive rehabilitation for schizophrenia: problems, prospects, and strategies. Schizophr. Bull. 1999;25(2):257–274
  2. Brenner HD, Hodel B, Roder V, Corrigan P. Treatment of cognitive dysfunctions and behavioral deficits in schizophrenia. Schizophr. Bull. 1992;18(1):21–26
  3. Brenner HD, Roder V, Hodel B, Kienzle N, Reed D, Liberman R. Integrated Psychological Therapy for Schizophrenic Patients. Toronto, Canada: Hogrefe & Huber; 1994;
  4. Bowen L, Wallace C, Glynn S, Nuechterlein K, Lutzger J, Kuehnel T. Schizophrenics' cognitive functioning and performance in interpersonal interactions and skills training procedures. J. Psychiatry Res. 1994;28(3):289–301
  5. Buchanan RW, Holstein C, Breier A. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biol. Psychiatry. 1994;36(11):717–725
  6. Bulbena A, Fernández de Larrinoa P, Domı́nguez AI. Adaptación castellana de la escala LSP (Life Scale Profile) perfil de habilidades de la vida cotidiana. Actas Luso-Esp. Neurol. Psiquiatr. 1992;20(2):51–60
  7. Cassens G, Inglis AH, Applebaum PS, Gutheil TG. Neuroleptics: effects on neuropsychological functioning in chronic schizophrenic patients. Schizophr. Bull. 1990;1:477–499
  8. Delahunty A, Morice R. The Frontal Executive Program. A Neurocognitive Rehabilitation Program For Schizophrenia. 2nd ed.. Albury, NSW, Australia: New South Wales Department of Health; 1993;
  9. Fernández de Larrinoa P, Bulbena A, Domı́nguez AI. Estudio de fiabilidad, validez y consistencia interna de la escala LSP (Life Scale Profile) perfil de habilidades de la vida cotidiana. Actas Luso-Esp. Neurol. Psiquiatr. 1992;20(2):71–75
  10. Goldberg T, Greenberg R, Griffin S, Griffin S, Gold J, Kleinmam J, et al. The effects of clozapine on psychiatric symptoms in patients with schizophrenia. Br. J. Psychiatry. 1993;162:43–48
  11. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia?. Schizophr. Bull. 1999;153:321–330
  12. Green MF, Nuechterlein KH. Should schizophrenia be treated as a neurocognitive disorder?. Schizophr. Bull. 1999;25(2):309–311
  13. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?. Schizophr. Bull. 2000;26(1):119–136
  14. Hayes R, McGrath JJ. Cognitive rehabilitation for people with schizophrenia and related conditions: a systematic review and meta-analysis. Cohrane Database Syst. Rev. 2000; (3) CD000968
  15. Heaton RH, Gladsjo JA, Palmer BP, Kuck J, Marcotte TD, Jeste DV. Stability and course of neuropsychological deficits in schizophrenia. Arch. Gen. Psychiatry. 2001;58:24–32
  16. Heim H, Wolf S, Gothe H, Kretschmer J. Kognitive training bei schizophrenen Erkrankungen. Psychiatr. Neurol. Med. Psychol. 1989;41(6):367–375
  17. Hodel B, Brenner HD. Cognitive therapy with schizophrenic patients: conceptual basis, present state, future directions. Acta Psychiatr. Scand. 1994;90:108–115
  18. Kay SR, Sevy S. Pyramidical model of schizophrenia. Schizophr. Bull. 1990;16(3):537–545
  19. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987;13:261–276
  20. Keefe RSE, Silva S, Perkins D, Lieberman JA. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia. Schizophr. Bull. 1999;25:201–222
  21. Kraemer S, Sulz K, Schmid R, Lassle R. Kognitive Therapie bei standardversorgten schizophrenen Patienten. Nervenartz. 1987;58(2):84–90
  22. Lezak MD. The Rationale of Deficit Measurement. In: Neuropsychological Assessment. 2nd ed.. New York: Oxford Univ. Press; 1983;p. 85–98
  23. Meltzer H, Lee M, Ranjan R. Recent advances in the pharmacotherapy of schizophrenia. Acta Psychiatr. Scand. 1994;90(Suppl. 384):95–101
  24. Morice R. Cognitive inflexibility and pre-frontal dysfunction in schizophrenia and mania. Br. J. Psychiatry. 1990;157:50–54
  25. Morice R, Delahunty A. Frontal/executive impairments in schizophrenia. Schizophr. Bull. 1996;22:125–137
  26. Olbrich R, Mussgay L. Reduction of schizophrenia deficits by cognitive training. An evaluative study. Eur. Arch. Psychiatry. 1990;239:366–369
  27. Parker G, Rosen A, Emdur N, Hadzi-Pavlov D. The life skills profile: psychometric properties of a measure assessing function and disability in schizophrenia. Acta Psychiatr. Scand. 1991;83:145–152
  28. Penadés R, Boget T, Salamero M, Catarineu S, Bernardo M. Alteraciones neuropsicológicas en la esquizofrenia y su modificación. Actas Esp. Psiquiatr. 1999;27(3):198–208
  29. Penadés R, Boget T, Lomeña F, Bernardo M, Mateos JJ, Laterza C, et al. Brain perfusion and neuropsychological changes in schizophrenic patients after cognitive rehabilitation. Psychiatry Res.-Neuroimaging. 2000;98(2):127–132
  30. Penadés R, Gastó C, Boget T, Catalán R, Salamero M. Deficit in schizophrenia: the relationship between negative symptoms and neurocognition. Compr. Psychiatry. 2001;42(1):64–69
  31. Penn D, Mueser K, Spaulding W, Reed D. Information processing and social competence in chronic schizophrenia. Schizophr. Bull. 1995;21:269–281
  32. Peralta V, Cuesta MJ. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res. 1994;53:31–40
  33. Roder V, Brenner HD, Hodel B, Kienzle N. Terapia Integrada de la Esquizofrenia. Barcelona: Ariel Psiquiatrı́a; 1996;
  34. Rosen A, Hadzi-Pavlov D, Parker G. The life skills profile: a measure assessing function and disability in schizophrenia. Schizophr. Bull. 1989;15:325–337
  35. Rund BR, Borg NE. Cognitive deficits and cognitive training in schizophrenic patients: a review. Acta Psychiatr. Scand. 1999;100:85–95
  36. Spaulding WD, Fleming SK, Reed D, Sullivan M, Storzbach D, Lam M. Cognitive functioning in schizophrenia: implications for psychiatric rehabilitation. Schizophr. Bull. 1999;25(2):275–289
  37. Spaulding WD, Reed D, Sullivan M, Richardson C, Weiler M. Effects of cognitive treatment in psychiatric rehabilitation. Schizophr. Bull. 1999;25(4):657–676
  38. Spohn H, Strauss M. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J. Abnorm. Psychol. 1989;98:367–380
  39. Van de Gaag M. The Results of Cognitive Training in Schizophrenic Patients. Delft, the Netherlands: Eburon; 1992;
  40. Van de Gaag M, Woonings F, Van den Bosch R, Appelo M, Sloof C, Louwerens J. Cognitive training in schizophrenic patients: a behavioral approach based on experimental psychopathology. In:  Spaulding W editors. Cognitive Technology in Psychiatric Rehabilitation. Lincoln, NE: University of Nebraska Press; 1994;p. 139–158
  41. Wechsler D. Escala de Inteligencia para Adultos. 8th ed.. Madrid: Tea; 1990;
  42. Weinberger D, Lipska B. Cortical maldevelopment, antipsychotics drugs and schizophrenia: a search for common ground. Schizophr. Res. 1995;16:87–110
  43. Wykes T. What are we changing with neurocognitive rehabilitation? Illustrations from two single cases in neuropsychological performance and brain systems as measured by SPECT. Schizophr. Res. 1998;34(9):77–86
  44. Wykes T, Dunn G. Cognitive deficit and the prediction of rehabilitation success in a chronic psychiatric group. Psychol. Med. 1992;22:389–398
  45. Wykes T, Sturt E, Katz R. The prediction of rehabilitative success after three years: the use of social, symptom and cognitive variables. Br. J. Psychiatry. 1990;157:865–870
  46. Wykes T, Reeder C, Corner J, Williams C, Everitt B. The effects of neurocognitive remediation on executive processing in patients with schizophrenia. Schizophr. Bull. 1999;24:291–308
  47. Wykes T, Reeder C, Corner J. The prevalence and stability of an executive processing deficit, response inhibition, in people with chronic schizophrenia. Schizophr. Res. 2000;46:241–253

PII: S0920-9964(02)00359-6

doi: 10.1016/S0920-9964(02)00359-6

Schizophrenia Research
Volume 63, Issue 3 , Pages 219-227 , 1 October 2003

Article Tools

* Image Usage & Resolution